injectable glp 1 agonist Real-World Use of GLP-1s Yields Less Weight Loss Than Clinical Trials Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
The approval status and availability of this class of drugs vary widely across the globe
doi: 10.1210/jc.2018-01176 70 KanetoHTakamiASprangerRAmanoAWatanabeDNiemoellerE
Moreover, GLP-1RAs may affect tumor initiation and progression by modulating microRNA expression patterns and influencing epigenetic modifications
In type 2 diabetes, the primary therapeutic objective is to reduce blood glucose levels and lower HbA1c
